This inventor holds 16 USPTO granted patents, primarily in Cognitive Disorders Treatment. Top assignees: Eli Lilly and Company, Spectrum Pharmaceuticals, Inc., Sprectrum Pharmaceuticals, Inc.. Active years: 1995-2014.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Springfield, VA (US) (2001)
- Lake Forest, CA (US) (2001)
- Greenfield, IN (US) (1995 - 2002)
- Mission Viejo, CA (US) (2004)
- Irvine, CA (US) (2005 - 2014)
Company Filing History:
10 out of 4,522 
5 out of 38 
1 out of 1 Years Active: 1995-2014
Areas of Expertise:
Title: Innovations of David R. Helton: A Pioneer in Cognitive Disorder Treatments
Introduction
David R. Helton is an esteemed inventor based in Irvine, California, who has made significant contributions to the field of cognitive and attention deficit disorders. With a total of 16 patents to his name, Helton's work has focused on the development of novel methods and compounds aimed at improving cognitive health.
Latest Patents
Among his latest innovations are patented methods for treating cognitive and attention deficit disorders through the use of tetrahydroindolone analogues and derivatives. These patents detail the efficacy of tetrahydroindolone derivatives in therapeutic applications, providing valuable insights into potential treatments for individuals struggling with cognitive challenges. His contributions in this area reflect a strong commitment to enhancing mental health through scientific innovation.
Career Highlights
Throughout his career, David R. Helton has worked with prominent companies such as Eli Lilly and Company and Spectrum Pharmaceuticals, Inc. These experiences in leading pharmaceutical firms have enriched his expertise and have allowed him to refine his research and development skills in the healthcare sector.
Collaborations
In his journey as an inventor, Helton has collaborated with notable professionals such as Mary Jeanne Kallman and Alvin Jerald Glasky. These collaborations have facilitated the exchange of ideas and have fostered a productive environment for innovation, contributing to the success of his projects.
Conclusion
David R. Helton's dedication to inventing solutions for cognitive and attention deficit disorders demonstrates his important role in advancing medical science. By leveraging his knowledge and experiences, he continues to pave the way for innovative treatments that may significantly improve the quality of life for countless individuals. His work stands as a testament to the impact that a single inventor can have on the broader field of healthcare and innovation.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile